Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

You may also like


Weeding out duplicates to better detect side-effects

Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.

Research / 25 April 2024

vigiVec through the Research Corner lens

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 15 November 2023

Making medicines safer for pregnant and breastfeeding women

Pregnancy and breastfeeding can be a chaotic period, exacerbated by lack of safety information for drugs taken during this time. The IMI ConcePTION project aims to change that.

Research / 17 October 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more